CYTK vs EXEL
Cytokinetics vs Exelixis — AI-powered side-by-side comparison
| Metric | CYTK | EXEL |
|---|---|---|
| AI Score | 54 | 63 |
| Price | $77.06 | $53.05 |
| P/E Ratio | -11.29× | 17.00× |
| ROE | 1.2% | 0.4% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.9% | 1.0% |
| Debt / Equity | -1.56× | 0.09× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 32.6 | 31.9 |
| Beta | 0.422 | 0.424 |
| Expected Upside | +3.8% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
CYTK Full Analysis
EXEL Full Analysis